Everlife, the pan-Asian healthcare platform of private equity firm Everstone Capital, has appointed Raman Gandotra as its new CEO.
Gandotra will be based out of Singapore and will lead Everlife through its next stage of growth, Everstone said in a statement.
Prior to this, Gandotra was leading the India and Southeast Asia business of British medical technology company Smith & Nephew. Gandotra, who has 30 years of work experience, has earlier held leadership roles in the Indian and Southeast Asian businesses of pharmaceutical companies Baxter and Allergan.
Everstone had launched Everlife in late-2017. The healthcare platform had made its debut bet by backing Malaysian medical products distributor Chemopharm Sdn Bhd. At the time, it had said Everlife would be led by Troy Bailey, who has 20 years of experience in medical device businesses in Asia, including a stint with GE Healthcare.
In March, Everlife inked its first India deal, making an investment in in-vitro diagnostics products manufacturer CPC Diagnostics Pvt. Ltd.
Everstone, which was founded in 2006, has about $5 billion in assets under management in private equity and real estate investments.
The firm has offices in Singapore, Mumbai, Delhi, Bengaluru, Mauritius, New York and London.
Everstone has expanded its healthcare portfolio with new bets this year. In April, the private equity firm agreed to acquire a controlling stake in Pune-based hospital chain Sahyadri Hospitals Ltd. Last month, it said it had acquired a significant minority stake in medical devices firm Translumina Therapeutics.
